Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q3, 2025 Earnings Conference Call.
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q3, 2025 Earnings Conference Call. An audio recording of this webcast will be available shortly after the call today on ...
Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsIlan Sobel - Chief Executive OfficerBar Dichter ...
Data from the NSF-funded Zwicky Transient Facility pinpointed the energy source: J2245+3743, an active galactic nucleus 500 ...
One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, ...
A world-famous light experiment from 1801 has now been carried out with sound for the first time. Research by physicists in ...
Last time I wrote about new data that overturns the standard cosmological model. Before anyone starts dusting off their ...
As the digital advertising industry enters a new phase of maturity, so does its relationship with data. Going into 2026, ...
Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. CNBC Select will update as changes are made public.